Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06897527 | A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC) | not yet recruiting | Phase 4 | 100 | GlaxoSmithKlineINDUSTRY | 0 | Jul 8, 2025 | clinicaltrials |
| NCT06942377 | Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy | not yet recruiting | Phase 2 | 140 | Peking University People's HospitalOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT07048327 | Cohort Study of Intrauterine Diseases(TJ Intrauterin) | recruiting | — | 2,000 | Wenwen WangOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07040657 | Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue | recruiting | N/A | 100 | Dokuz Eylul UniversityOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT06360653 | a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer(SISTER-RAY) | recruiting | N/A | 60 | ARNAS Civico Di Cristina Benfratelli HospitalOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06977594 | Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer | not yet recruiting | N/A | 1,000 | Seoul National University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07028229 | Ultrasound Training Program for Gynecologic Cancer Staging in Residents(Ultra-teaching) | not yet recruiting | N/A | 6 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT07028242 | Ultrasound and Histology in AEH and Early EEC Treated Conservatively(ULTRA-SAFE) | not yet recruiting | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT02288676 | DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics(DOvEEgene) | recruiting | — | 1,200 | McGill UniversityOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT07025213 | Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery. | recruiting | N/A | 80 | National Institute of CancerologíaOTHER_GOV | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07015593 | Patient Journey in Advanced Gynecologic Cancers | not yet recruiting | — | 780 | Tongji HospitalOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06073184 | Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium(WE-FiERCE) | not yet recruiting | Phase 2 | 71 | University Health Network, TorontoOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT07006103 | Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification | not yet recruiting | — | 400 | Hospital Italiano de Buenos AiresOTHER | 0 | Jun 8, 2025 | clinicaltrials |
| NCT06990971 | Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health(CYCLE_ENDO) | not yet recruiting | — | 200 | Cycle Therapeutics LtdINDUSTRY | 0 | May 25, 2025 | clinicaltrials |
| NCT05795244 | Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) | recruiting | Phase 2 | 30 | Yonsei UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06963385 | Radiomics and Molecular Classification in Endometrial Cancer(ROME) | active not recruiting | N/A | 250 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05647109 | Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer | recruiting | — | 244 | Peking University People's HospitalOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT04706962 | TH1902 in Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 70 | TheratechnologiesINDUSTRY | 2 | Apr 15, 2025 | clinicaltrials |
| NCT05857631 | Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study(PARCERII) | recruiting | N/A | 90 | Tata Memorial CentreOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06917092 | QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer(QLPPEC/GOG-003) | recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06901778 | Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation | not yet recruiting | N/A | 106 | Peking University People's HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT05179447 | PROfiling Based Endometrial Cancer Adjuvant Therapy(PROBEAT) | recruiting | N/A | 590 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT04570553 | Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers | recruiting | N/A | 350 | WellSpan HealthOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06893861 | Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer | recruiting | — | 3,100 | National Cancer Institute, NaplesOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06870903 | Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer(ENDONOTE) | recruiting | N/A | 52 | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06887673 | Lipid Mediators & Cancer: Montelukast, SPM, and Almonds | not yet recruiting | Early Phase 1 | 56 | University of South FloridaOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT04008563 | Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium(B-FiERCE) | recruiting | N/A | 36 | University Health Network, TorontoOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06871787 | Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery(INOCA) | not yet recruiting | Phase 4 | 50 | Istanbul UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT04196257 | BP1001-A in Patients With Advanced or Recurrent Solid Tumors | recruiting | Phase 1 | 50 | Bio-Path Holdings, Inc.INDUSTRY | 1 | Mar 7, 2025 | clinicaltrials |
| NCT00005095 | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention | recruiting | — | 6,000 | Northwestern UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06841653 | A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer. | recruiting | — | 40 | Regina Elena Cancer InstituteOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05591131 | Genetic Testing in African Americans(GTM-I) | active not recruiting | N/A | 21 | Augusta UniversityOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05669430 | A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies | recruiting | Phase 1 / Phase 2 | 365 | GV20 TherapeuticsINDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06677242 | Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study(SEIC) | not yet recruiting | — | 100 | Erasmus Medical CenterOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT05032040 | A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies | active not recruiting | Phase 2 | 170 | Xencor, Inc.INDUSTRY | 1 | Feb 7, 2025 | clinicaltrials |
| NCT03212404 | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | active not recruiting | Phase 1 | 272 | Checkpoint Therapeutics, Inc.INDUSTRY | 9 | Feb 3, 2025 | clinicaltrials |
| NCT06805864 | Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma(BROTHER) | not yet recruiting | Phase 2 | 45 | Gunma UniversityOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06800612 | Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers | recruiting | — | 100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06800677 | Methylated Biomarkers Predictive of Endometrial Cancer Risk(BioMEC) | active not recruiting | — | 200 | University of ManchesterOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06758557 | A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor | recruiting | Phase 1 / Phase 2 | 282 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06787807 | Proteomic Analysis of Patients Undergoing Bariatric Surgery | not yet recruiting | N/A | 103 | Universidade Federal de PernambucoOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06781216 | Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial Cancer | not yet recruiting | N/A | 66 | Akdeniz UniversityOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06774209 | Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06771154 | Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial(A-CAPE) | not yet recruiting | Phase 2 | 140 | Peking Union Medical College HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06307886 | Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator | recruiting | — | 108 | Gaziosmanpasa Research and Education HospitalOTHER_GOV | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06584032 | Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer | recruiting | Phase 3 | 412 | HutchmedINDUSTRY | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06751277 | QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer | not yet recruiting | Phase 2 | 26 | xiang yangOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06745427 | A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia(PreFerEC/EIN) | not yet recruiting | — | 100 | Region StockholmOTHER_GOV | 0 | Dec 20, 2024 | clinicaltrials |
| NCT06737640 | Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer(Immuno-Gyn) | not yet recruiting | — | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Dec 17, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jul 8, 2025source: clinicaltrials